|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||
| 化学式 | C24H29N7O5 |
||||||||||
| 分子量 | 495.53 | CAS No. | 1062169-56-5 | ||||||||
| Solubility (25°C)* | 体外 | DMSO | 99 mg/mL (199.78 mM) | ||||||||
| Water | Insoluble | ||||||||||
| Ethanol | Insoluble | ||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||
| 製品説明 | WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) not P-AKT(T308), selective for mTOR than PI3Kα (>100-fold) and PI3Kγ (>500-fold). |
|---|---|
| in vitro | WYE-354 also inhibits several PI3Ks at micromolar levels. In HEK293 cells, this compound (0.2 μM–5 μM) effectively inhibits both mTORC1 and mTORC2. It (0.3 μM–10 μM) significantly blocks mTOR signaling and Akt activation in U87MG and MDA361 cells. Furthermore, this chemical potently inhibits proliferation in tumor cell lines including MDA-MB-361, MDA-MB-231, MDA-MB-468, LNCap, A498, and HCT116, with IC50 values ranging from 0.28 μM to 2.3 μM. The apoptosis induced by this compound is accompanied by G1 cell cycle arrest and caspases activation. In endothelial HUVEC cells, it (10 nM–1 μM) also inhibits both mTORC1 and mTORC2 signaling, as revealed by dephosphorylation of S6 ribosomal protein and Akt, respectively. Furthermore, this chemical (10 nM–1 μM) activates mitogen-activated protein kinase (MAPK) signaling, which may be due to its inhibition of mTORC1. |
| in vivo | In a mice xenograft model of PTEN-null PC3MM2 tumor, WYE-354 (50 mg/kg) effectively inhibits mTOR signaling and tumor growth. |
| キナーゼアッセイ | mTOR inhibitor assays | |
|---|---|---|
| The assays are performed in 96-well plates for 2 hours at room temperature in 25 μL containing 6 nM Flag-TOR(3.5), 1 μM His6-S6K, and 100 μM ATP. The assays are performed and detected by DELFIA employing the Eu-phospho-p70S6K T389 antibody. For inhibitor versus ATP matrix competition, mTOR kinase reactions are carried out with varying concentrations of ATP (0, 25, 50 100, 200, 400, and 800 μM) in combination with varying concentrations of this compound. The assays contained 12 nM Flag-TOR(3.5), 1 μM His-S6K, and are incubated for 30 min. The assay results are similarly detected by DELFIA and processed for generation of double-reciprocal plots. | ||
| 細胞アッセイ | 細胞株 | Tumor cell lines including MDA-MB-361, MDA-MB-231, MDA-MB-468, LNCap, DU145, A498, and HCT116 |
| 濃度 | 0–50 μM, dissolved in DMSO | |
| 反応時間 | 72 hours | |
| 実験の流れ | Cells are plated in 96-well plates at 1000 to 3000 cells per well for 24 hours, treated with DMSO or varying concentrations of WYE-354. Viable cell densities are determined 72 hours later by MTS assay employing a CellTiter 96 kit. The effect of each treatment is calculated as percent of control growth relative to the DMSO-treated cells grown in the same culture plate. Inhibitor dose response curves are plotted for determination of IC50 values. | |
| 動物実験 | 動物モデル | Nude mice (BALB/c, nu/nu, female) bearing PC3MM2 xenograft |
| 投薬量 | 50 mg/kg | |
| 投与方法 | Administered via intraperitoneal injection | |
|

, , Dr. Zhang of Tianjin Medical University

, , Dr. Yong-Weon Yi from Georgetown University Medical Center

, , Dr. Pierre P. Roger from Free University of Brussels
| A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures [ Cancers (Basel), 2020, 12(12)E3519] | PubMed: 33255925 |
| WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines. [ Oncol Rep, 2019, 41(6):3179-3188] | PubMed: 30942458 |
| miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model [Callegari E, et al. Mol Ther Nucleic Acids, 2018, 11:485-493] | PubMed: 29858083 |
| Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells [ Int J Oncol, 2018, 52(3):828-840] | PubMed: 29344641 |
| The Toxmatrix: Chemo-Genomic Profiling Identifies Interactions That Reveal Mechanisms of Toxicity [ Chem Res Toxicol, 2018, 31(2):127-136] | PubMed: 29156121 |
| Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo. [Wang L, et al. Tumour Biol, 2016, 37(9):11743-11752] | PubMed: 27020593 |
| β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells. [Yi YW, et al. Exp Mol Med, 2015, 47:e143] | PubMed: 25721419 |
| NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth. [ Cancer Lett, 2015, 359(1):97-106] | PubMed: 25578782 |
| NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth. [Zha X, et al. Cancer Lett, 2015, 359(1):97-106] | |
| mTOR regulates phagosome and entotic vacuole fission. [Krajcovic M, et al. Mol Biol Cell, 2013, 24(23):3736-45] | PubMed: 24088573 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。